NDC00087-0519-41 — THEOPHYLLINE EXTENDED-RELEASE TA

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00087-0519-41: THEOPHYLLINE EXTENDED-RELEASE TA.

THEOPHYLLINE EXTENDED-RELEASE TA. Key specifications include special_features: ANHYDROUS, primary_container_type: BOTTLE, therapeutic_equivalent: QUIBRON-T/SR BY BRISTOL-MYERS SQUIBB PHARMACEUTICAL, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-159-9250, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00087-0519-41

NSN: 6505-01-159-9250
FSC: 6505 — Drugs and Biologicals
CAGE: 13811 — BRISTOL-MYERS SQUIBB CO WESTWOOD-SQUIBB PHARMACEUTICALS DIV (USA)

SPECIFICATIONS

special_features	ANHYDROUS
primary_container_type	BOTTLE
therapeutic_equivalent	QUIBRON-T/SR BY BRISTOL-MYERS SQUIBB PHARMACEUTICAL
primary_container_content_quantity	100.000 TABLETS
active_medicament_medicinal_strength	300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT
NSN	6505-01-159-9250

COMPONENT DIAGRAM

KEY FEATURES

•

THERAPEUTIC EQUIVALENT: QUIBRON-T/SR BY BRISTOL-MYERS SQUIBB PHARMACEUTICAL

•

PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS

•

PRIMARY CONTAINER TYPE: BOTTLE

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT

TECHNICAL CHARACTERISTICS

THERAPEUTIC EQUIVALENT	QUIBRON-T/SR BY BRISTOL-MYERS SQUIBB PHARMACEUTICAL
PRIMARY CONTAINER CONTENT QUANTITY	100.000 TABLETS
PRIMARY CONTAINER TYPE	BOTTLE
SPECIAL FEATURES	ANHYDROUS
PART NAME ASSIGNED BY CONTROLLING AGENCY	THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT
ACTIVE MEDICAMENT MEDICINAL STRENGTH	300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT

SUBSTITUTES & CROSS-REFERENCES 2

NDC61570-0019-01Reference document

Same NSN cross-reference

Reference document — Design control — primary reference

QUIBRON-T/SRReference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required

Ready to buy NDC00087-0519-41?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00087-0519-41?

NDC00087-0519-41 is a THEOPHYLLINE EXTENDED-RELEASE TA.

What parts can replace NDC00087-0519-41?

There are 2 known substitutes for NDC00087-0519-41: NDC61570-0019-01, QUIBRON-T/SR. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00087-0519-41?

NDC00087-0519-41 is cataloged in the U.S. Government catalog under NSN 6505-01-159-9250. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00087-0519-41 — THEOPHYLLINE EXTENDED-RELEASE TA

Request a Quote — NDC00087-0519-41